Hui Yu

机构：The Ohio State University

发表论文 33 篇 · 总被引 315 次 · h-index 8

代表论文

• Repeated loss of target surface antigen after immunotherapy in primary mediastinal large B cell lymphoma (2016 · American Journal of Hematology · 被引 93)
• Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma (2021 · Molecular Therapy — Oncolytics · 被引 49)
• The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma (2021 · Cancers · 被引 35)
• Circular RNA circ_0029589 regulates proliferation, migration, invasion, and apoptosis in ox-LDL-stimulated VSMCs by regulating miR-424-5p/IGF2 axis (2020 · Vascular Pharmacology · 被引 35)
• Anti‐CD47 immunotherapy in combination with BCL‐2 inhibitor to enhance anti‐tumor activity in B‐cell lymphoma (2022 · Hematological Oncology · 被引 25)
• Injectable magnesium-bisphosphonate MOF-based bone adhesive prevents excessive fibrosis for osteoporotic fracture repair (2025 · Nature Communications · 被引 19)